1. The incidence of pancreatic cancer in recent years have significantly increased trend.
2. Pancreatic cancer early without typical clinical manifestations, abdominal pain need to identify many diseases, so prone to misdiagnosis and mistreatment, the misdiagnosis rate in the 35.5% to 87.5%, and often misdiagnosed as cholecystitis ﹑ ﹑ gastrointestinal diseases, such as hepatitis ﹑ pancreatitis.
3. Misprision of pancreatic cancer clinical manifestations, it is not easy early detection, 80% of the patients already advanced when diagnosed, the low rate of surgical resection, about 5% to 15%.
4. Pancreatic cancer can be divided into parts by the anatomy of pancreatic cancer ﹑ ﹑ pancreatic carcinoma of the pancreas tail cancer, the most common pancreatic cancer.
5. CA19-9 is the most hopeful signs in the early diagnosis of pancreatic cancer, the diagnosis rate of 90%.
6. Pancreatic cancer tumors are not sensitive to radiation, local radiotherapy, will enable 30% to 50% of the patients pain relief, and to some extent may inhibit tumor development.
7.70 percent of pancreatic cancer patients increased serum CEA, CEA can be used for pancreatic cancer after surgery before ﹑ the dynamic follow-up regularly on the CEA forecast of cancer recurrence be a valuable reference.
8. Weight loss ﹑ abdominal back pain ﹑ three major symptoms of jaundice is pancreatic cancer, pancreatic cancer can be oppressive violations of celiac plexus led to violent persistent abdominal pain.
9. Chemotherapy no significant effect on pancreatic cancer, coupled with the lower rate of surgical resection, effective pancreatic cancer-specific anti-cancer therapy is the main treatment, the system effective anticancer drug treatment plant activity will be part of pancreatic cancer patients with long-term survival of .
10 clinicians should strictly control pancreatic cancer surgery and chemotherapy indications indications.
11. Pancreatic cancer apparent abdominal back pain are mostly cancer pain, cancer treatment is effective analgesic premise.